Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA.
about
Ziconotide: a review of its pharmacology and use in the treatment of painThe Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialStructural Basis for Pharmacology of Voltage-Gated Sodium and Calcium ChannelsThe alpha2delta auxiliary subunit reduces affinity of omega-conotoxins for recombinant N-type (Cav2.2) calcium channelsTargeting chronic and neuropathic pain: the N-type calcium channel comes of age.Characterization of novel cannabinoid based T-type calcium channel blockers with analgesic effects.1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.Role of Na(v)1.9 in activity-dependent axon growth in motoneurons.Analgesic effect of highly reversible ω-conotoxin FVIA on N type Ca2+ channelsSO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.Molecular surface of tarantula toxins interacting with voltage sensors in K(v) channelsProlonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA.Voltage-gated calcium channels and idiopathic generalized epilepsies.A Conus regularis conotoxin with a novel eight-cysteine framework inhibits CaV2.2 channels and displays an anti-nociceptive activityChallenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief.Is there a role for T-type Ca2+ channels in regulation of vasomotor tone in mesenteric arterioles?Calcium channel functions in pain processingCalcium-permeable ion channels in pain signaling.Targeting voltage-gated calcium channels in neurological and psychiatric diseases.Screening and Validation of Highly-Efficient Insecticidal Conotoxins from a Transcriptome-Based Dataset of Chinese Tubular Cone Snail.Anticonvulsant mechanisms of piperine, a piperidine alkaloid.Subtype-specific reduction of voltage-gated calcium current in medium-sized dorsal root ganglion neurons after painful peripheral nerve injury.Spider peptide Phα1β induces analgesic effect in a model of cancer pain.Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.Block of T-type calcium channels by protoxins I and II.Electrophysiological characterization of activation state-dependent Ca(v)2 channel antagonist TROX-1 in spinal nerve injured rats.Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.Depolarization-induced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels.New Conotoxin SO-3 Targeting N-type Voltage-Sensitive Calcium Channels.Omega-conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels.Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.Effect of the spider toxin Tx3-3 on spinal processing of sensory information in naive and neuropathic rats: an in vivo electrophysiological study.Glycerotoxin stimulates neurotransmitter release from N-type Ca2+ channel expressing neurons
P2860
Q24658327-399E9290-3DC1-4240-8AB5-BB3DFF010B65Q26781422-4B526E22-D696-4615-A29B-1A9F0160079AQ28082803-7B87FF82-2958-41DC-BD33-92DEB489E65DQ28263842-C9B2C16A-284B-4B78-AD79-0726E3EBEC3CQ30501239-96C15F7A-EDC1-4787-A8EF-8C812DCEFF0BQ30631622-2CD8B506-4E44-49B0-9ED3-71605F173C31Q31170459-E878D3D8-2FDB-4CFF-B611-5F70D1FE0F1CQ34284951-87CCB4A9-04A2-4B1F-8073-96B1FF66B617Q34515732-0F43496C-0CB9-4FE8-B4C5-A5ADEA3629D3Q35048992-BAA7C7DB-AFEC-4398-AA2C-4849C457D5ACQ36159142-32AA2549-5F51-46E7-98A2-61813FD51621Q36412562-822157DF-091B-4AC3-ACDE-8087AA8F7638Q36481655-6619BD33-8C69-4173-802E-5DE5872EF345Q36525559-21C5D0E5-835E-4BCF-B7D8-3A408C8647C6Q36994234-9CEE83C8-F1DE-4ECE-9B14-548F68880A5CQ37360619-F11CBAAF-DEC8-436F-B68D-B74455BED9E2Q37362037-3AABBE8E-6E23-4095-B629-B4EC16071153Q37367889-F40240EC-F4CD-46B6-994A-DE135B198688Q37819805-EA1FA401-0338-43D0-AA8E-F838F7B42113Q38175134-CE6D066A-6611-4C98-B6B3-2B46E81FDE8BQ38626606-0DDBE4EB-5190-44BD-8A78-946A780F4133Q38690231-29ABE837-F35D-45D6-BDFD-9D09C0339672Q38821684-5A25DC2C-0CC5-40ED-BFA8-A1F874404FDEQ38963057-13BB8F66-477A-4AC0-8C49-84A0EC88C84AQ39146129-EF140088-7F84-4C67-B45A-6196125AA6A5Q39577731-F5DB8392-5EAA-45F1-8E22-F286A271A74FQ39854878-79AA439E-865F-4750-AA17-65037150179AQ40811975-063071CA-B14F-47C5-8F59-C7B5B7078B23Q42723075-452EFB85-D06C-49BA-8540-BB2BD46735B7Q43262406-192B1FA8-98C6-4EBB-B6EC-13B2B63511AFQ46776177-C1283682-4B24-4018-A0C9-8A40EC440DCCQ48802729-7A02BE97-4825-45BB-9247-28A85113B339Q48918282-BB66BD16-3FCE-47AE-B4FA-B3E2EBB775DBQ49372721-13F95D62-BD0E-40F1-A218-0676CCBAEF4FQ58120721-07022CC8-B71E-4266-9CF1-5F2D3FAFC0CC
P2860
Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Determinants of inhibition of ...... ega-conotoxins GVIA and MVIIA.
@en
type
label
Determinants of inhibition of ...... ega-conotoxins GVIA and MVIIA.
@en
prefLabel
Determinants of inhibition of ...... ega-conotoxins GVIA and MVIIA.
@en
P2093
P2860
P356
P1476
Determinants of inhibition of ...... mega-conotoxins GVIA and MVIIA
@en
P2093
Clinton J Doering
J David Spafford
Robert J Winkfein
Zhong-Ping Feng
P2860
P304
20171-20178
P356
10.1074/JBC.M300581200
P407
P577
2003-03-24T00:00:00Z